♥
ISIN : INE727B01026
NSE : GENESYS
BSE : 506109
Face Value : 5
Industry : IT - Software
EPS : 5.74
EPS (TTM) : 12.06
Price to Earning (P/E) : 125.49
Book Value : 122.24
Price to Bookvalue (P/B) : 5.89
Dividend Yield : 0 %
Return on Equity (ROE) : 4.99 %
Return on Capital Employed (ROCE) : 8.53 %
Genesys International Corporation Limited
ISIN : INE727B01026
NSE : GENESYS
BSE : 506109
Face Value : 5
Industry : IT - Software
EPS : 5.74
EPS (TTM) : 12.06
Price to Earning (P/E) : 125.49
Book Value : 122.24
Price to Bookvalue (P/B) : 5.89
Dividend Yield : 0 %
Return on Equity (ROE) : 4.99 %
Return on Capital Employed (ROCE) : 8.53 %
Genesys International share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 233.95 - 237.85 1.7 % |
| Low / High | 223.55 - 239.3 7 % |
| Trade Volume | 35,902 |
| 52 Week Low / High | 205.9 - 757 267.7 % |
-
YOU MAY ALSO LIKE
- Stock market course tutorial
Stock Market Investment Course explained in simple words. - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Share Market basics for beginners
Share Market jargons in simple terms - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
CONSOLIDATED QUARTERLY RESULT FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 426.94 | 373.82 | 544.29 | 466.23 | 345.48 | 331.88 | 593.35 | 711.72 | 557.57 | 720.24 |
| Total Income | 440.66 | 393.09 | 562.21 | 480.33 | 354.73 | 342.95 | 618.69 | 716.33 | 571.65 | 730.21 |
| Total Expenditure | 309.62 | 264.19 | 350.75 | 303.04 | 287.44 | 254.79 | 285.65 | 349.16 | 353.47 | 426.42 |
| Other Income | 13.72 | 19.27 | 17.92 | 14.1 | 9.25 | 11.07 | 25.34 | 4.6 | 14.08 | 9.97 |
| Operating Profit | 131.04 | 128.9 | 211.46 | 177.29 | 67.29 | 88.16 | 333.04 | 367.17 | 218.18 | 303.79 |
| Interest | 5.4 | 5.56 | 3.51 | 12.19 | 6.65 | 7.23 | 10.88 | 14.34 | 12.42 | 18.82 |
| PBDT | 125.64 | 123.34 | 207.95 | 165.1 | 60.64 | 80.93 | 322.16 | 352.83 | 205.76 | 284.97 |
| Depreciation | 81.39 | 89.04 | 93.05 | 108.62 | 113 | 109.4 | 110.58 | 111.82 | 118 | 122.53 |
| Profit Before Tax | 44.25 | 34.3 | 114.9 | 56.48 | -52.36 | -28.47 | 211.58 | 241.01 | 87.76 | 162.44 |
| Tax | 24.59 | 2.01 | 37.64 | 36.4 | 2.28 | 5.89 | 54.35 | 93.12 | 34.8 | 51.54 |
| Profit After Tax | 19.66 | 32.29 | 77.26 | 20.08 | -54.64 | -34.36 | 157.23 | 147.89 | 52.96 | 110.9 |
| Net Profit | 19.66 | 32.29 | 77.26 | 20.08 | -54.64 | -34.36 | 157.23 | 147.89 | 52.96 | 110.9 |
| Equity Capital | 157.39 | 184.35 | 184.62 | 188.78 | 188.87 | 189.02 | 189.18 | 197.7 | 197.99 | 198.17 |
| Face Value (IN RS) | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Calculated EPS | 1.36 | 1.3 | 2.13 | 0.57 | -1.41 | -0.87 | 4.19 | 3.76 | 1.36 | 2.83 |
| Diluted Eps After Extraordinary Items | 1.27 | 1.36 | 2.14 | 0.61 | -1.4 | -0.49 | 4.21 | 3.75 | 1.33 | 2.77 |
| Diluted Eps Before Extraordinary Items | 1.27 | 1.36 | 2.14 | 0.61 | -1.4 | -0.49 | 4.21 | 3.75 | 1.33 | 2.77 |
STANDALONE QUARTERLY RESULT FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 426.23 | 371.35 | 540.7 | 460.85 | 341.73 | 328.51 | 577.1 | 697.31 | 552.58 | 709.22 |
| Total Income | 440.34 | 390.42 | 558.83 | 473.94 | 353.84 | 339.59 | 602.53 | 701.08 | 566.67 | 719.19 |
| Total Expenditure | 307.69 | 262.29 | 349.14 | 295.92 | 285.77 | 253.22 | 282.88 | 328.7 | 346.35 | 416.35 |
| Other Income | 14.12 | 19.07 | 18.13 | 13.09 | 12.11 | 11.07 | 25.43 | 3.76 | 14.08 | 9.97 |
| Operating Profit | 132.65 | 128.13 | 209.69 | 178.02 | 68.07 | 86.37 | 319.65 | 372.38 | 220.32 | 302.84 |
| Interest | 5.6 | 5.45 | 3.5 | 12.19 | 6.65 | 7.3 | 10.82 | 14.33 | 12.42 | 18.82 |
| PBDT | 127.05 | 122.68 | 206.19 | 165.83 | 61.42 | 79.07 | 308.83 | 358.05 | 207.9 | 284.02 |
| Depreciation | 24.96 | 30.15 | 32.38 | 49.03 | 52.87 | 48.39 | 49 | 51.69 | 57.12 | 60.73 |
| Profit Before Tax | 102.09 | 92.53 | 173.81 | 116.8 | 8.55 | 30.68 | 259.83 | 306.36 | 150.78 | 223.29 |
| Tax | 24.58 | 2 | 37.64 | 36.39 | 2.28 | 5.89 | 54.35 | 91.12 | 34.8 | 51.54 |
| Profit After Tax | 77.51 | 90.53 | 136.17 | 80.41 | 6.27 | 24.79 | 205.48 | 215.24 | 115.98 | 171.75 |
| Net Profit | 77.51 | 90.53 | 136.17 | 80.41 | 6.27 | 24.79 | 205.48 | 215.24 | 115.98 | 171.75 |
| Equity Capital | 157.39 | 184.35 | 184.62 | 188.78 | 188.87 | 189.02 | 189.18 | 197.7 | 197.99 | 198.17 |
| Face Value (IN RS) | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Calculated EPS | 2.46 | 2.46 | 3.69 | 2.13 | 0.17 | 0.66 | 5.43 | 5.44 | 2.93 | 4.33 |
| Diluted Eps After Extraordinary Items | 2.26 | 2.55 | 3.71 | 2.24 | 0.17 | 0.37 | 5.44 | 5.44 | 2.9 | 4.29 |
| Diluted Eps Before Extraordinary Items | 2.26 | 2.55 | 3.71 | 2.24 | 0.17 | 0.37 | 5.44 | 5.44 | 2.9 | 4.29 |
CONSOLIDATED ANNUAL RESULT FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 1196.29 | 1811.28 | 1982.43 |
| Total Income | 1229.98 | 1876.3 | 2032.69 |
| Total Expenditure | 921.57 | 1227.59 | 1177.04 |
| Other Income | 33.69 | 65.02 | 50.26 |
| Operating Profit | 308.41 | 648.71 | 855.65 |
| Interest | 24.78 | 26.66 | 39.09 |
| Exceptional Items | -451.07 | ||
| PBDT | -167.44 | 622.05 | 816.56 |
| Depreciation | 191.26 | 372.09 | 444.8 |
| Profit Before Tax | -358.7 | 249.96 | 371.76 |
| Tax | 38.17 | 100.64 | 155.63 |
| Profit After Tax | -396.87 | 149.32 | 216.13 |
| Net Profit | -396.87 | 149.32 | 216.13 |
| Equity Capital | 156.81 | 188.78 | 197.7 |
| Face Value (IN RS) | 5 | 5 | 5 |
| Reserves | 1891.27 | 3865.34 | 4693.92 |
| Calculated EPS | 4.28 | 5.05 | 5.58 |
| Diluted Eps After Extraordinary Items | 4.13 | 5.29 | 5.74 |
| Diluted Eps Before Extraordinary Items | 4.13 | 5.29 | 5.74 |
STANDALONE ANNUAL RESULT FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 1196.29 | 1799.12 | 1944.66 |
| Total Income | 1240.4 | 1863.52 | 1997.03 |
| Total Expenditure | 915.77 | 1215.05 | 1150.57 |
| Other Income | 44.11 | 64.4 | 52.38 |
| Operating Profit | 324.63 | 648.47 | 846.46 |
| Interest | 24.56 | 26.74 | 39.09 |
| Exceptional Items | -1003.89 | ||
| PBDT | -703.82 | 621.73 | 807.37 |
| Depreciation | 101.84 | 136.52 | 201.95 |
| Profit Before Tax | -805.66 | 485.21 | 605.42 |
| Tax | 38.14 | 100.62 | 153.64 |
| Profit After Tax | -843.8 | 384.59 | 451.78 |
| Net Profit | -843.8 | 384.59 | 451.78 |
| Equity Capital | 156.81 | 188.78 | 197.7 |
| Face Value (IN RS) | 5 | 5 | 5 |
| Reserves | 1806.43 | 4253.96 | 5314.09 |
| Calculated EPS | -26.91 | 10.19 | 11.43 |
| Diluted Eps After Extraordinary Items | -25.01 | 10.65 | 11.75 |
| Diluted Eps Before Extraordinary Items | -25.01 | 10.65 | 11.75 |
CONSOLIDATED PROFIT / LOSS FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 79.56 Cr | 119.63 Cr | 181.13 Cr | 198.24 Cr |
| Software Services & Operating Revenues | 79.56 Cr | 116.51 Cr | 181.13 Cr | 198.24 Cr |
| Operating Income (Net) | 79.56 Cr | 119.63 Cr | 181.13 Cr | 198.24 Cr |
| Power & Fuel Cost | 1.1 Cr | 1.14 Cr | 1.59 Cr | 1.82 Cr |
| Electricity & Power | 1.1 Cr | 1.14 Cr | 1.59 Cr | 1.82 Cr |
| Employee Cost | 46.07 Cr | 45.79 Cr | 53.12 Cr | 45.05 Cr |
| Salaries, Wages & Bonus | 43.94 Cr | 40.28 Cr | 45.34 Cr | 36.72 Cr |
| Contributions to EPF & Pension Funds | 2.15 Cr | 2.54 Cr | 3.51 Cr | 3.24 Cr |
| Wheeling & Transmission Charges recoverable | 18.65 Lk | 61.2 Lk | 44.86 Lk | 64.6 Lk |
| Cost of Software developments | 16.6 Cr | 34.88 Cr | 50.27 Cr | 54.26 Cr |
| Technical sub-contractors | 1.96 Cr | 0 | 0 | 0 |
| General and Administration Expenses | 6.33 Cr | 4.74 Cr | 9.31 Cr | 8.28 Cr |
| Professional and legal fees | 3.09 Cr | 2.45 Cr | 5.78 Cr | 4.9 Cr |
| Miscellaneous Expenses | 12.55 Cr | 5.48 Cr | 8.19 Cr | 7.65 Cr |
| Bad debts /advances written off | 19.88 Lk | 0 | 0 | 0 |
| Loss on sale of non-trade current investments | -84,000 | 2.09 Lk | 0 | 0 |
| Total Expenditure | 82.65 Cr | 92.03 Cr | 122.49 Cr | 117.06 Cr |
| Other Income | 1.74 Cr | 3.37 Cr | 6.5 Cr | 5.03 Cr |
| Interest Received | 71.97 Lk | 30.83 Lk | 41.2 Lk | 87.58 Lk |
| Profit on sale of Fixed Assets | 5.27 Lk | 0 | 20,000 | 15.51 Lk |
| Profits on sale of Investments | 39.51 Lk | 14.45 Lk | 0 | 0 |
| Provision Written Back | 0 | 74.52 Lk | 0 | 2.16 Cr |
| Foreign Exchange Gains | 7.77 Lk | 1.46 Cr | 3.14 Cr | 68.51 Lk |
| Operating Profit | -1.36 Cr | 30.97 Cr | 65.14 Cr | 86.21 Cr |
| Interest | 3.11 Cr | 2.61 Cr | 2.94 Cr | 4.56 Cr |
| Intereston Term Loan | 1.05 Cr | 1.06 Cr | 1.69 Cr | 3.18 Cr |
| Bank Charges etc | 19.52 Lk | 13.01 Lk | 27.24 Lk | 64.71 Lk |
| PBDT | -4.47 Cr | 28.36 Cr | 62.2 Cr | 81.66 Cr |
| Depreciation | 18.77 Cr | 19.13 Cr | 37.21 Cr | 44.48 Cr |
| Profit Before Taxation & Exceptional Items | -23.23 Cr | 9.24 Cr | 25 Cr | 37.18 Cr |
| Exceptional Income / Expenses | -31.21 Cr | -45.11 Cr | 0 | 0 |
| Profit Before Tax | -54.44 Cr | -35.87 Cr | 25 Cr | 37.18 Cr |
| Provision for Tax | -2.66 Cr | 3.82 Cr | 10.06 Cr | 15.56 Cr |
| Current Income Tax | 0 | 2.5 Cr | 9 Cr | 10.79 Cr |
| Deferred Tax | -2.95 Cr | 1.31 Cr | 62.16 Lk | 5.24 Cr |
| Profit After Tax | -51.79 Cr | -39.69 Cr | 14.93 Cr | 21.61 Cr |
| Minority Interest | 8.86 Cr | 53.1 Cr | 4.15 Cr | 46.06 Lk |
| Consolidated Net Profit | -42.93 Cr | 13.41 Cr | 19.08 Cr | 22.07 Cr |
| Profit Balance B/F | 129.34 Cr | 81.48 Cr | 84.24 Cr | 59.59 Cr |
| Appropriations | 86.41 Cr | 94.89 Cr | 103.32 Cr | 81.67 Cr |
| Earnings Per Share | -13.75 | 4.28 | 5.05 | 5.58 |
| Adjusted EPS | -13.75 | 4.28 | 5.05 | 5.58 |
STANDALONE PROFIT / LOSS FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 79.56 Cr | 119.63 Cr | 179.91 Cr | 194.47 Cr |
| Software Services & Operating Revenues | 79.56 Cr | 116.51 Cr | 179.91 Cr | 194.47 Cr |
| Operating Income (Net) | 79.56 Cr | 119.63 Cr | 179.91 Cr | 194.47 Cr |
| Power & Fuel Cost | 1.1 Cr | 1.14 Cr | 1.59 Cr | 1.82 Cr |
| Electricity & Power | 1.1 Cr | 1.14 Cr | 1.59 Cr | 1.82 Cr |
| Employee Cost | 46.07 Cr | 45.79 Cr | 53.12 Cr | 44.89 Cr |
| Salaries, Wages & Bonus | 43.94 Cr | 40.28 Cr | 45.34 Cr | 36.56 Cr |
| Contributions to EPF & Pension Funds | 2.15 Cr | 2.54 Cr | 3.51 Cr | 3.24 Cr |
| Wheeling & Transmission Charges recoverable | 18.66 Lk | 61.2 Lk | 44.86 Lk | 64.6 Lk |
| Cost of Software developments | 16.22 Cr | 34.5 Cr | 49.86 Cr | 52.21 Cr |
| Technical sub-contractors | 1.96 Cr | 0 | 0 | 0 |
| General and Administration Expenses | 6.2 Cr | 4.65 Cr | 8.54 Cr | 7.91 Cr |
| Professional and legal fees | 3 Cr | 2.4 Cr | 5.1 Cr | 4.65 Cr |
| Miscellaneous Expenses | 11.98 Cr | 5.37 Cr | 8.13 Cr | 7.6 Cr |
| Bad debts /advances written off | 19.88 Lk | 0 | 0 | 0 |
| Loss on sale of non-trade current investments | 0 | 2.09 Lk | 0 | 0 |
| Total Expenditure | 81.57 Cr | 91.45 Cr | 121.24 Cr | 114.43 Cr |
| Other Income | 2.84 Cr | 4.41 Cr | 6.44 Cr | 5.24 Cr |
| Interest Received | 1.79 Cr | 1.4 Cr | 55.47 Lk | 93.56 Lk |
| Profit on sale of Fixed Assets | 5.27 Lk | 0 | 20,000 | 15.51 Lk |
| Profits on sale of Investments | 40.7 Lk | 14.45 Lk | 0 | 0 |
| Provision Written Back | 12.98 Lk | 74.52 Lk | 0 | 2.16 Cr |
| Foreign Exchange Gains | 7.77 Lk | 1.46 Cr | 3.14 Cr | 68.51 Lk |
| Operating Profit | 82.92 Lk | 32.59 Cr | 65.11 Cr | 85.28 Cr |
| Interest | 3.15 Cr | 2.58 Cr | 2.94 Cr | 4.54 Cr |
| Intereston Term Loan | 1.09 Cr | 1.04 Cr | 1.69 Cr | 3.18 Cr |
| Bank Charges etc | 19.37 Lk | 12.61 Lk | 26.59 Lk | 62.97 Lk |
| PBDT | -2.32 Cr | 30.01 Cr | 62.17 Cr | 80.74 Cr |
| Depreciation | 9.82 Cr | 10.18 Cr | 13.65 Cr | 20.2 Cr |
| Profit Before Taxation & Exceptional Items | -12.13 Cr | 19.82 Cr | 48.52 Cr | 60.54 Cr |
| Exceptional Income / Expenses | -27.85 Cr | -100.39 Cr | 0 | 0 |
| Profit Before Tax | -39.98 Cr | -80.57 Cr | 48.52 Cr | 60.54 Cr |
| Provision for Tax | -2.65 Cr | 3.81 Cr | 10.06 Cr | 15.36 Cr |
| Current Income Tax | 0 | 2.5 Cr | 9 Cr | 10.59 Cr |
| Deferred Tax | -2.94 Cr | 1.31 Cr | 61.94 Lk | 5.24 Cr |
| Profit After Tax | -37.33 Cr | -84.38 Cr | 38.46 Cr | 45.18 Cr |
| Consolidated Net Profit | -37.33 Cr | -84.38 Cr | 38.46 Cr | 45.18 Cr |
| Profit Balance B/F | 218.06 Cr | 183.14 Cr | 95.46 Cr | 126.72 Cr |
| Appropriations | 180.73 Cr | 98.76 Cr | 133.92 Cr | 171.89 Cr |
| Earnings Per Share | -11.96 | -26.9 | 10.19 | 11.43 |
| Adjusted EPS | -11.96 | -26.9 | 10.19 | 11.43 |
CONSOLIDATED CASH FLOW FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -54.44 Cr | -35.87 Cr | 25 Cr | 37.18 Cr |
| Adjustment | 70.81 Cr | 62.92 Cr | 39.99 Cr | 49.76 Cr |
| Changes In working Capital | 14.17 Cr | 3.06 Cr | -93.55 Cr | -65.82 Cr |
| Cash Flow after changes in Working Capital | 30.53 Cr | 30.1 Cr | -28.57 Cr | 21.12 Cr |
| Cash Flow from Operating Activities | 28.83 Cr | 27.48 Cr | -35.19 Cr | 19.07 Cr |
| Cash Flow from Investing Activities | -19.3 Cr | -19.28 Cr | -188.48 Cr | -79.61 Cr |
| Cash Flow from Financing Activitie | -10.89 Cr | 11.91 Cr | 214.86 Cr | 71.24 Cr |
| Net Cash Inflow / Outflow | -1.35 Cr | 20.1 Cr | -8.82 Cr | 10.7 Cr |
| Opening Cash & Cash Equivalents | 2.74 Cr | 1.38 Cr | 21.38 Cr | 12.56 Cr |
| Closing Cash & Cash Equivalent | 1.38 Cr | 21.48 Cr | 12.56 Cr | 23.27 Cr |
STANDALONE CASH FLOW FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -39.98 Cr | -80.57 Cr | 48.52 Cr | 60.54 Cr |
| Adjustment | 47.08 Cr | 112.34 Cr | 17.89 Cr | 25.41 Cr |
| Changes In working Capital | 13.61 Cr | 10.59 Cr | -84.04 Cr | -64.9 Cr |
| Cash Flow after changes in Working Capital | 20.71 Cr | 42.37 Cr | -17.63 Cr | 21.05 Cr |
| Cash Flow from Operating Activities | 18.81 Cr | 39.5 Cr | -24.25 Cr | 18.99 Cr |
| Cash Flow from Investing Activities | -12.31 Cr | -22.86 Cr | -208.7 Cr | -79.98 Cr |
| Cash Flow from Financing Activitie | -7.83 Cr | 3.44 Cr | 222.16 Cr | 71.02 Cr |
| Net Cash Inflow / Outflow | -1.33 Cr | 20.08 Cr | -10.8 Cr | 10.02 Cr |
| Opening Cash & Cash Equivalents | 2.68 Cr | 1.35 Cr | 21.33 Cr | 10.53 Cr |
| Closing Cash & Cash Equivalent | 1.35 Cr | 21.43 Cr | 10.53 Cr | 20.56 Cr |
CONSOLIDATED BALANCE SHEET FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
STANDALONE BALANCE SHEET FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
FINANCIAL RATIOS (CONSOLIDATED) FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -13.75 | 4.28 | 5.05 | 5.58 |
| CEPS(Rs) | -10.58 | -6.56 | 13.81 | 16.72 |
| Book NAV/Share(Rs) | 55.5 | 64.14 | 101.52 | 122.24 |
| Tax Rate(%) | 4.88 | -10.64 | 40.26 | 41.86 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -3.89 | 23.07 | 32.38 | 40.95 |
| EBIT Margin(%) | -64.52 | -27.8 | 15.42 | 21.05 |
| Pre Tax Margin(%) | -68.43 | -29.98 | 13.8 | 18.75 |
| PAT Margin (%) | -65.09 | -33.17 | 8.24 | 10.9 |
| Cash Profit Margin (%) | -41.51 | -17.19 | 28.79 | 33.34 |
| Performance Ratios | ||||
| ROA(%) | -16.88 | -13.7 | 3.8 | 3.9 |
| ROE(%) | -26.86 | -21.2 | 5.11 | 4.99 |
| ROCE(%) | -25.52 | -16.43 | 8.43 | 8.53 |
| Asset Turnover(x) | 0.26 | 0.41 | 0.46 | 0.36 |
| Sales/Fixed Asset(x) | 0.23 | 0.35 | 0.54 | 0.48 |
| Working Capital/Sales(x) | 1.91 | 2.18 | 1.04 | 0.89 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 4.28 | 2.9 | 1.84 | 2.06 |
| Receivable days | 182.68 | 124.24 | 133.37 | 207.95 |
| Payable days | 79.24 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 0 | 133.37 | 65.09 | 105.83 |
| PCE(x) | -9.68 | -87 | 23.82 | 35.34 |
| Price/Book(x) | 1.84 | 8.89 | 3.24 | 4.83 |
| EV/Net Sales(x) | 4.06 | 14.93 | 6.94 | 11.66 |
| EV/Core EBITDA(x) | -238.25 | 57.68 | 19.28 | 26.81 |
| EV/EBIT(x) | -6.3 | -53.71 | 44.97 | 55.39 |
| EV/CE(x) | 1.18 | 5.95 | 2.6 | 4.27 |
| M Cap / Sales | 4.02 | 14.95 | 6.86 | 11.78 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -28.83 | 50.37 | 51.41 | 9.45 |
| Core EBITDA Growth(%) | -107.8 | 8119.58 | 110.33 | 32.34 |
| EBIT Growth(%) | -1304.64 | 33.96 | 183.99 | 49.39 |
| PAT Growth(%) | -918.35 | 23.37 | 137.63 | 44.74 |
| EPS Growth(%) | -2364.13 | 131.1 | 18.17 | 10.47 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.04 | 0.1 | 0.08 | 0.11 |
| Current Ratio(x) | 2.13 | 1.71 | 3.52 | 3.02 |
| Quick Ratio(x) | 2.13 | 1.71 | 3.52 | 3.02 |
| Interest Cover(x) | -16.5 | -12.75 | 9.51 | 9.16 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | 0.03 | 0.02 |
FINANCIAL RATIOS (STANDALONE) FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -11.96 | -26.9 | 10.19 | 11.43 |
| CEPS(Rs) | -8.81 | -23.66 | 13.8 | 16.53 |
| Book NAV/Share(Rs) | 82.81 | 61.44 | 111.82 | 137.93 |
| Tax Rate(%) | 6.63 | -4.73 | 20.74 | 25.38 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -2.53 | 23.56 | 32.61 | 41.16 |
| EBIT Margin(%) | -46.3 | -65.19 | 28.6 | 33.47 |
| Pre Tax Margin(%) | -50.26 | -67.35 | 26.97 | 31.13 |
| PAT Margin (%) | -46.93 | -70.53 | 21.38 | 23.23 |
| Cash Profit Margin (%) | -34.59 | -62.02 | 28.96 | 33.62 |
| Performance Ratios | ||||
| ROA(%) | -12.46 | -32 | 10.09 | 7.52 |
| ROE(%) | -13.49 | -37.4 | 12.51 | 9.34 |
| ROCE(%) | -12.94 | -33 | 15.04 | 12.06 |
| Asset Turnover(x) | 0.27 | 0.45 | 0.47 | 0.32 |
| Sales/Fixed Asset(x) | 0.61 | 0.87 | 1.1 | 0.98 |
| Working Capital/Sales(x) | 1.22 | 1.82 | 1.04 | 0.88 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.64 | 1.14 | 0.91 | 1.02 |
| Receivable days | 209.63 | 133.07 | 135.39 | 213.32 |
| Payable days | 70.95 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 0 | 0 | 32.29 | 51.7 |
| PCE(x) | -11.61 | -24.11 | 23.83 | 35.73 |
| Price/Book(x) | 1.24 | 9.28 | 2.94 | 4.28 |
| EV/Net Sales(x) | 4.06 | 14.86 | 6.99 | 11.9 |
| EV/Core EBITDA(x) | 389.56 | 54.55 | 19.32 | 27.13 |
| EV/EBIT(x) | -8.77 | -22.8 | 24.45 | 35.55 |
| EV/CE(x) | 1.17 | 7.16 | 2.44 | 3.84 |
| M Cap / Sales | 4.02 | 14.95 | 6.9 | 12.01 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -28.83 | 50.37 | 50.39 | 8.09 |
| Core EBITDA Growth(%) | -95.64 | 1710.66 | 99.79 | 30.97 |
| EBIT Growth(%) | -631.19 | -117.42 | 165.99 | 26.47 |
| PAT Growth(%) | -774.72 | -126.01 | 145.58 | 17.47 |
| EPS Growth(%) | -772.95 | -125.02 | 137.86 | 12.17 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.02 | 0.06 | 0.08 | 0.09 |
| Current Ratio(x) | 2.98 | 2.01 | 3.54 | 3.06 |
| Quick Ratio(x) | 2.98 | 2.01 | 3.54 | 3.06 |
| Interest Cover(x) | -11.71 | -30.2 | 17.5 | 14.34 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | 0.03 | 0.02 |
SHARE HOLDING PATTERN FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 16.75 | 14.30 | 14.28 | 13.96 | 13.96 | 13.94 | 13.93 | 13.33 | 13.31 | 12.81 |
| FII % | 2.13 | 4.04 | 4.03 | 3.96 | 3.79 | 3.77 | 2.14 | 6.12 | 5.80 | 5.55 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.10 | 0.07 | 0.19 |
| Public % | 47.19 | 55.29 | 52.76 | 53.78 | 53.97 | 54.03 | 55.65 | 53.44 | 53.85 | 54.49 |
PEER COMPARISON FOR GENESYS INTERNATIONAL CORPORATION LIMITED
CORPORATE ACTIONS FOR GENESYS INTERNATIONAL
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 22-Oct-2024 | Board Meeting - Quarterly Results | 28-Oct-2024 |
| BSE 19-Sep-2024 | Book Closure - A.G.M. | 24-Sep-2024 30-Sep-2024 |
| BSE 19-Sep-2024 | AGM - A.G.M. | 30-Sep-2024 30-Sep-2024 |
| BSE 08-Aug-2024 | Board Meeting - Quarterly Results | 14-Aug-2024 |
| BSE 24-May-2024 | Board Meeting - Audited Results | 30-May-2024 |
| BSE 08-Feb-2024 | Board Meeting - Quarterly Results | 14-Feb-2024 |
| BSE 27-Oct-2023 | Board Meeting - Quarterly Results | 03-Nov-2023 |
| BSE 01-Sep-2023 | Book Closure - A.G.M. | 22-Sep-2023 28-Sep-2023 |
| BSE 01-Sep-2023 | AGM - A.G.M. | 28-Sep-2023 28-Sep-2023 |
| BSE 08-Aug-2023 | Board Meeting - Quarterly Results | 14-Aug-2023 |
| BSE 24-May-2023 | Board Meeting - Audited Results | 30-May-2023 |
| BSE 08-Feb-2023 | Board Meeting - Quarterly Results | 14-Feb-2023 |
| BSE 16-Dec-2022 | Board Meeting - Amalgamation | 19-Dec-2022 |
| BSE 09-Nov-2022 | Board Meeting - Quarterly Results | 14-Nov-2022 |
| BSE 20-Sep-2022 | Book Closure - A.G.M. | 24-Sep-2022 30-Sep-2022 |
| BSE 20-Sep-2022 | AGM - A.G.M. | 30-Sep-2022 30-Sep-2022 |
| BSE 08-Aug-2022 | Board Meeting - Quarterly Results | 12-Aug-2022 |
| BSE 10-Jun-2022 | Board Meeting - Employees Stock Option Plan & Preferential Issue of shares | 14-Jun-2022 |
| BSE 31-May-2022 | Board Meeting - Audited Results (Revised) | 07-Jun-2022 |
| BSE 24-May-2022 | Board Meeting - Audited Results | 30-May-2022 |
| BSE 18-Apr-2022 | SAST - Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that our subsidiary, A. N. VirtualWorld Limited ('ANVWL') has transferred its entire shareholding in its wholly owned Indian Subsidiary viz. Virtual World Spatial Technologies Pvt. Ltd. toGenesys International Corporation Limited (GICL). Please find enclosed the details of t... | |
| BSE 07-Feb-2022 | Board Meeting - Quarterly Results | 14-Feb-2022 |
| BSE 20-Oct-2021 | Board Meeting - Quarterly Results | 26-Oct-2021 |
| BSE 01-Sep-2021 | AGM - inter alia,approved: i. Annual General meeting to be held on September 30, 2021 at 3.00 p.m. through Video Conferencing/ Other Audio-Visual Means ii. The Register of Members and Share Transfer Book of the Company will remain closed from September 24, 2021 to September 30, 2021 for the purpose of AGM iii. Shareholders as on Cut-off date viz. September 23, 2021 may cast their vote electronically. Th... | 30-Sep-2021 |
| BSE 01-Sep-2021 | Book Closure - A.G.M. | 24-Sep-2021 30-Sep-2021 |
CORPORATE ANNOUNCEMENTS FOR GENESYS INTERNATIONAL
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 30-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed a copy of newspaper publication of Un-audited standalone and consolidated financials of the Company for the quarter and half year ended September 30 2024 as published in the Newspaper- The Free Press Journal (English) and Navshakti ( Marathi). |
| BSE 30-Oct-2024 | General Announcements FILE | Press Release Please find attached a copy of press release titled "Genesys International Partners with SatSure to elevate Geospatial Solutions in Aviation forestry Disaster Management Utilities" |
| BSE 28-Oct-2024 | Compliance FILE | Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations 2015 For The Quarter Ended September 30 2024 In compliance with Regulation 32(1) 0f SEBI (Lasting Obligations and Disclosure Requirements) Regulations 2015 please find attached the Statement of Deviation or Variation or Utilization of fund raised through Preferential Issue by the Company for the quarter ended September 30 2024 as revived by the Audit Committee |
| BSE 28-Oct-2024 | General Announcements FILE | Press Release- Un-Audited Financial Results (Standalone And Consolidated) For The Second Quarter And Half Year Ended September 30 2024. In continuation to our letter dated October 28 2024 on the Un-audited financial results (standalone and consolidated) for the second quarter and half year ended September 2024 please find enclosed a copy of the press release being issue by the Company in the regard. |
| BSE 28-Oct-2024 | Outcome FILE | Board Meeting Outcome for Un-Audited Financial Results For Quarter And Half Year Ended 30 September 2024 the Board of Directors of the Company at their meeting held today has inter alia considered and approved following:-1. Un-audited Financial Results (Standalone & Consolidated) for the quarter and halfyear ended September 30 2024 along with Limited Review Report of StatutoryAuditors. Copies of the following enclosed:a. Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30 2024.b. Limited Review Report of the Statutory Auditors on aforesaid results. |
| BSE 28-Oct-2024 | Outcome FILE | Results- Financial Results For Quarter And Half Year Ended 30Th September 2024 The Board of Directors of the Company at their meeting held today inter alia considered and approved Un-audited financial results (standalone and consolidated for the quarter and half year ended 30th September 2024. Enclosed financial Results and limited review report |
| BSE 22-Oct-2024 | Intimation FILE | Board Meeting Intimation for Intimation Of Board Meeting To Approve The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2024 GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Pursuant to the provisions under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable provisions rules and regulations if any this is to inform you that a meeting of the Board of Directors of the Company will be held at registered office on Monday October 28 2024 to inter alia consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30 2024. |
| BSE 18-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS The Nomination and Remuneration Committee at its Meeting held on October 18 2024 has approved the allotment of 59 696 equity shares of face value of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees of the Company under the Genesys ESOP Scheme-2020 and Genesys ESOP Scheme-2022 |
| BSE 10-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In compliance with Regulation 74(5) of SEBI(DP) Regulations 2018 we are enclosing herewith the certificate received from M/s Bigshare Services Pvt Ltd the RTA of the Company for the quarter ended September 30 2024 |
| BSE 01-Oct-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Pursuant to Regulation 44(3) of SEBI(LODR) Regulations 2015 please find attached voting results of the business transacted along with consolidated/combined Scrutinizers Report with respect to the 42nd AGM of the Company held on September 30 2024 at 04:30 PM |
| BSE 30-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Please find attached summary of proceedings of the 42nd AGM of the Company held on Monday September 30 2024 at 04:30 P.M through Video Conferencing/Other audio visual means |
| BSE 30-Sep-2024 | Intimation FILE | Closure of Trading Window This is to inform that the Trading Window for dealing in securities of the Company shall remain closed from Tuesday October 01 2024. The Trading Window will open 48 hours after the declaration of financial results of the Company for the quarter ended September 30 2024 |
| BSE 28-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Directorate Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby inform that Mr. Ganesh Acharya (DIN: 00702346)has completed his second term as an Independent Director on September 28 2024. Consequently he ceased to be the Independent Director of the Company w.e.f the close of business hours of September 28 2024 |
| BSE 27-Sep-2024 | General FILE | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 26 2024 for Sajid Malik |
| BSE 27-Sep-2024 | General Announcements FILE | Press Release Please find attached copy of press release titled" Genesys International Awarded Rs.35 crore Projects by NEOM and Saudi Geo-logical Survey" |
| BSE 14-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 30 of SEBI(LODR) Regulations 2015 we hereby enclose herewith copies of the newspaper advertisement published in The Free Press Journal (English) and Navshakti (Marathi) on September 14 2024 titled - "Transfer of Equity shares to IEPF Account" |
| BSE 07-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find attached a copy of advertisements published in newspaper- Free Press Journal (English) and Navshakti (Marathi) regarding Notice of 42nd Annual General Meeting (AGM) to be held on Monday September 30 2024 at 4:30 P.M. (IST) through Video conferencing (VC)/Other Audio visual means (OAVM). |
| BSE 06-Sep-2024 | General Announcements FILE | Business Responsibility and Sustainability Reporting (BRSR) In terms of provision of Regulation 34(2)(f) of SEBI(LODR) Regulations 2015 we are enclosing Business Responsibility and Sustainability Report for the Financial Year 2023-24 |
| BSE 06-Sep-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. In terms of provision of Regulation 34(1) of SEBI(LODR) Regulations 2015 please find enclosed the 42nd Annual Report for the FY 2023-24 along with the notice of 42nd AGM of the Company to be held on Monday September 30 2024 at 4.30 p.m through Video Conferencing or Other Audio Visual Means |
| BSE 06-Sep-2024 | Intimation FILE | Shareholder Meeting - AGM On September 30 2024 In terms of provisions of Regulation 34(1) of SEBI(LODR) Regulations 2015 please find enclosed the 42nd Annual Report for the FY 2023-24 along with the Notice of the 42nd AGM of the Company to be held on Monday September 30 2024 at 4.30p.m IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM) |
| BSE 04-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS The Nomination and Remuneration Committee at its meeting held on September 04 2024 has approved the allotment of 32 090 equity shares of face value of Rs. 5/- each pursuant to the exercise of the Stock Options by the eligible employees of the Company under the Genesys ESOP Scheme-2010 Genesys ESOP Scheme-2020 and Genesys ESOP Scheme-2022. |
| BSE 17-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed a copy of newspaper publication of Unaudited Standalone and consolidated financial Results of the Company for the quarter ended June 30 2024 as published in the newspapers - The Free Journal (English) and Navshakti (Marathi) |
| BSE 14-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press release - Un-audited Financial Results (standalone and consolidated ) for the quarter ended June 30 2024 |
| BSE 14-Aug-2024 | Outcome FILE | Board Meeting Outcome for Financial Results (Standalone And Consolidated ) For Quarter Ended June 30 2024 The Board of Directors of the Company in its meeting held today considered and approved un-audited Financial Results (standalone and Consolidated ) for the quarter ended June 30 2024 |
| BSE 14-Aug-2024 | Outcome FILE | Results- Financial Results For Quarter Ended June 30 2024 The Board of Directors at their meeting held today has inter alia considered and approved Un-audited Financial results (standalone and consolidated) for quarter ended June 30 2024 |
| BSE 14-Aug-2024 | Compliance FILE | Compliances - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations 2015 For The Quarter Ended June 30 2024 In Compliance with the Regulation 32(1) of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 please find attached the Statement of Deviation or Variation or Utilization of funds raised through Preferential Issue by the Company for the quarter ended June 30 2024 as reviewed by the Audit Committee. |
| BSE 08-Aug-2024 | Intimation FILE | Board Meeting Intimation for Board Meeting Intimation For Approval Of Un-Audited (Standalone And Consolidated) Financial Results For The Quarter Ended June 30 2024 GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve GENESYS INTERNATIONAL CORPORATION LTD. has informed BSE that a meeting of the Board of Directors of the Company will be held at registered office on Wednesday August 14 2024 to inter alia consider and approve the Un-audited Financial Results (standalone and consolidated) for the quarter ended June 30 2024. |
| BSE 01-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS The Nomination and Remuneration Committee at its meeting held on August 01 2024 has approved the allotment of 3 500 equity shares of face value of Rs. 5/- each pursuant to the exercise of the stock Options by the eligible employees of the Company under the Genesys ESOP Scheme-2020 |
| BSE 12-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are enclosing herewith the certificate received from M/s. Bigshare Services Private Limited the Registrar and Share transfer Agent of the Company for the Quarter ended June 30 2024. |
| BSE 11-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Scheme of Arrangement Honble NCLT has approved the scheme of amalgamation of Virtual World Spatial Technologies Pvt Ltd wholly owned subsidiary (transferor company) with Genesys International Corporation Limited holding company (Transferee Company) and vide its order dated July 08 2024 |
INSIDER TRADING FOR GENESYS INTERNATIONAL
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 07-Dec-2023 08-Dec-2023 | Sell Market | 84,135 @ 0.00 (0.22 %) | Sudha Ganapathy |
| BSE 30-Nov-2023 30-Nov-2023 | Sell Market | 150,000 @ 0.00 (0.39 %) | Sudha Ganapathy |
| BSE 03-May-2022 03-May-2022 | Buy ESOP | 1,750 @ 0.00 (0.01 %) | Vineet Chopra |
| BSE 03-Jun-2022 03-Jun-2022 | Buy ESOP | 1,620 @ 0.00 (0.00 %) | Vineet Chopra |
| BSE 28-Mar-2022 28-Mar-2022 | Sell Market | 500,000 @ 0.00 (1.59 %) | Ganapathy Vishwanathan |
| BSE 23-Mar-2022 28-Mar-2022 | Sell Market | 2,059 @ 0.00 (0.01 %) | Tukaram Ature |
| BSE 28-Mar-2022 30-Mar-2022 | Sell Market | 2,732 @ 0.00 (0.00 %) | Shanazir Shaikh |
| BSE 17-Mar-2022 17-Mar-2022 | Sell Market | 3,600,000 @ 0.00 (0.43 %) | Mala Acharya |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 4,250 @ 0.00 (0.00 %) | Vineet Chopra |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Milind kshirsagar |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 2,500 @ 0.00 (0.01 %) | Sagar Patil |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Sandesh Kavatkar |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 3,000 @ 0.00 (0.00 %) | Kaustubh Chandorkar |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Lokendra J Koria |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 13,500 @ 0.00 (0.05 %) | Vivek Shetty |
| BSE 17-Feb-2022 17-Feb-2022 | Buy ESOP | 3,700 @ 0.00 (0.00 %) | Rehan Ansari |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 5,225 @ 0.00 (0.00 %) | Vasim Mukkadam |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Prashant Gawand |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Rahul Kumar Rai |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 2,880 @ 0.00 (0.00 %) | Kushal V Jain |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 5,250 @ 0.00 (0.00 %) | Bijendra Yadav |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 3,200 @ 0.00 (0.01 %) | Rajesh Kadam |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 11,000 @ 0.00 (0.04 %) | Sagar Patil |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 13,500 @ 0.00 (0.00 %) | Shanazir Shaikh |
| BSE 20-Jan-2022 20-Jan-2022 | Buy ESOP | 6,000 @ 0.00 (0.00 %) | Tukaram Ature |
BULK BLOCK DEALS FOR GENESYS INTERNATIONAL CORPORATION LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 31-Oct-2024 | Sell BULK | 325,000 @ 777.95 | KADAM HOLDING LIMITED |
| BSE 28-Mar-2022 | Sell BULK | 500,000 @ 600.00 | GANAPATHY VISWHANATHAN VEEMBIL |
DIVIDEND BY GENESYS INTERNATIONAL CORPORATION LIMITED
No dividend details found
SPLIT / BONUS BY GENESYS INTERNATIONAL CORPORATION LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
